SAILIFE
Sai Life Sciences Limited
Pharmaceuticals · ₹26,250 Cr market cap
A contract research and manufacturing organization serving the pharmaceutical and biotechnology industries, Sai Life Sciences conducts research activities and produces customized solutions for clients globally. Incorporated in 1999, the company operates as a specialized service provider, offering integrated capabilities across drug development, formulation, and manufacturing to support its customers' product pipelines and commercial operations in India and international markets.
6
Tracked investors holding
2
Tracked moves
₹1,234
Share price
Latest activity
Morgan StanleyNew position
Morgan Stanley bought 7,96,916 shares of Sai Life Sciences for ₹80.92 Cr at ₹1015.40 apiece in a block deal.
Top investors holding Sai Life Sciences Limited
2.94%
Plus 3 more tracked investors holding Sai Life Sciences Limited. Sign in to see them all.
Sign in to view all holdersTrack smart money in Sai Life Sciences Limited
Get alerted when a top investor buys or sells.
Get started